Loading...

DNA GINKGO BIOWORKS HOLDINGS INC Earnings Reports 8-K Filing

GNKG

DN

GINKGO BIOWORKS HOLDINGS INC

(DNA)

2026 8-K

Financial Results Update

Asset Acquisition

Stock Purchase Agreement

Financial Results

Management Transition

Q3 Financial Results

Sales Agreement Signed

Settlement Announcement

Financial Statements

Financial Statements

Financial Results

Management Changes

Stock Split Approval

Results of Operations and F...

Restructuring Plan and Head...

Annual Meeting of Shareholders

Delisting Notice

Financial Results and Restr...

Changes in Registrant s Cer...

Earnings Reports

Earnings Reports

Earnings Reports

Bylaws Amendment

Bankruptcy or insolvency

Acquisition and Financial U...

Financial Results Announcement

Annual Meeting of Shareholders

Financial Results Announcement

Resignation and Appointment

Disclosure of Bank Closure

Financial Results Announcement

Acquisition of Zymergen Inc.

Earnings Reports

External Links:

On May 7, 2026, Ginkgo Bioworks Holdings, Inc. announced its financial results for Q1 2026, providing updates on its operational performance. This filing is significant for investors and indicates the company's ongoing performance metrics.

AI Assistant

GINKGO BIOWORKS HOLDINGS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.